Post-COVID-19 rhino-orbito-cerebral mucormycosis-A clinico-mycological study from North India

被引:2
作者
Taneja, Juhi [1 ,7 ]
Chatterjee, Kuhu [1 ]
Sasidharan, Jaseetha [2 ]
Abbas, Syed Zafar [3 ]
Rai, Anil Kumar [2 ]
Raychaudhury, Sujata [4 ]
Das, Bhabatosh [5 ]
Das, Asim [6 ]
机构
[1] ESIC Med Coll & Hosp, Dept Microbiol, Faridabad, India
[2] ESIC Med Coll & Hosp, Dept ENT, Faridabad, India
[3] ESIC Med Coll & Hosp, Dept Radiol, Faridabad, India
[4] ESIC Med Coll & Hosp, Dept Pathol, Faridabad, India
[5] Translat Hlth Sci & Technol Inst, Faridabad, India
[6] ESIC Med Coll & Hosp, Faridabad, India
[7] ESIC Med Coll & Hosp, Dept Microbiol, Faridabad 121001, Haryana, India
关键词
mucormycosis; COVID-19-associated mucormycosis; rhino-orbito-cerebral mucormycosis; antifungal susceptibility; amphotericin B; MANAGEMENT; MUCOR;
D O I
10.1093/mmy/myad067
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The second wave of coronavirus disease 2019 (COVID-19), during the early 2021, lead to a devastating outbreak of mucormycosis in India. This study aimed to determine the aetiology, clinical features, comorbidities, and risk factors of rhino-orbito-cerebral mucormycosis (ROCM) and antifungal susceptibility pattern for the isolates. The study included all suspected cases of ROCM in post-COVID-19 patients attending the hospital from May to December 2021. A total of 70 patients were diagnosed with mucormycosis during the study period. The commonest presentations were rhino-orbital and rhino-orbito-cerebral in 35.7% of cases each. Diabetes mellitus was the commonest associated risk factor in 95.7% of all patients, while 78.5% of the patients were treated with corticosteroids in the recent past, and 25.7% presented with active COVID-19 pneumonia. The commonest isolate was Rhizopus arrhizus n = 14, followed by Aspergillus flavus n = 16, A. fumigatus n = 4, A. niger n = 3, Fusarium oxysporumn = 1, and Apophysomyces variabilisn = 1. Fungal species identification was done by phenotypic methods for all the isolates and DNA sequence analysis of 18 isolates, and antifungal susceptibility testing of 30 isolates was performed by commercially prepared HiMIC plate (HiMedia, Mumbai, India) using broth microdilution for amphotericin B, isavuconazole, itraconazole, voriconazole, and posaconazole. The MIC50 and MIC90 of amphotericin B for R. arrhizus strains were 0.25 and 4 & mu;g/ml, respectively; and the MIC50 and MIC90 results for itraconazole, posaconazole, and isavuconazole were 8 and 8, 2 and 2, and 2 and 8 & mu;g/ml, respectively. In vitro data showed that amphotericin B was the most effective antifungal against most species. The commercially available ready-to-use minimum inhibitory concentration plates are user-friendly for performing antifungal susceptibility, which may be useful in choosing appropriate regimens and monitoring emerging resistance.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Management of rhino-orbito-cerebral mucormycosis: a clinico-radiological study-an institutional experience
    Patnaik, Monica
    Jain, Rajat
    Singh, Abhishek Bahadur
    Kumar, Sunil
    Verma, Veerendra
    EGYPTIAN JOURNAL OF OTOLARYNGOLOGY, 2024, 40 (01)
  • [22] Corneal manifestations and treatment among patients with COVID-19-associated rhino-orbito-cerebral mucormycosis
    Yadav, Rekha
    Madan, Siddharth
    Rohatgi, Jolly
    Sahu, Pramod Kumar
    Das, Shukla
    Tandon, Anupama
    Rai, Puja
    Verma, Priya
    Singh, Jubin
    Bajaj, Ishita
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2023, 71 (01) : 101 - 108
  • [23] Rhino-orbito-cerebral mucormycosis: patient characteristics in pre-COVID-19 and COVID-19 period*
    Cherian, Lisa M.
    Varghese, Lalee
    Rupa, V
    Bright, Rakesh R.
    Abraham, Lisa
    Panicker, Raga
    Peter, Jayanthi
    Nayak, Aliva
    Shyam, Aparna
    Varghese, George M.
    Manesh, Abi
    Karuppusami, Reka
    George, Krupa
    George, Tina
    Lenin, Audrin
    Hansdak, Samuel George
    Ramya, I
    Michael, Joy Sarojini
    Ninan, Marilyn
    Thomas, Meera
    Kurian, Reshma
    Mammen, Shoba
    Kurien, Regi
    RHINOLOGY, 2022, 60 (06)
  • [24] Clinico-Radiological-Pathological Correlation of Visual Loss in COVID-Associated Rhino-Orbito-Cerebral Mucormycosis
    Goel, Ruchi
    Arora, Ritu
    Shah, Shalin
    Chhabra, Mohit
    Kumar, Jyoti
    Khurana, Nita
    Gupta, Swati
    Khanam, Samreen
    Kumar, Sumit
    Singh, Sonam
    Meher, Ravi
    Thakar, Meenakshi
    Garg, Anju
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2022, 38 (03) : 242 - 249
  • [25] Our children are at risk of COVID-19- associated rhino-orbito-cerebral mucormycosis (ROCM)
    Saied, AbdulRahman A.
    Metwally, Asmaa A.
    Dhama, Kuldeep
    ANNALS OF MEDICINE AND SURGERY, 2021, 72
  • [26] COVID-19 associated rhino-orbito-cerebral mucormycosis, risk factors and outcome predictors; a multicentric study
    Rajabi, Mohammad Taher
    Aghajani, Amirhossein
    Rafizadeh, Seyed Mohsen
    Tehrani, Mansooreh Jamshidian
    Lazarjani, Seyedeh Zahra Poursayed
    Keshmirshekan, Mohammad Mohsen
    Mohammadi, Abbas
    Akrami, Abbas
    Parandin, Mohammad Mehdi
    Rajabi, Mohammad Bagher
    Hosseini, Seyede Simindokht
    Akbari, Maryam
    INTERNATIONAL OPHTHALMOLOGY, 2023, 43 (04) : 1375 - 1386
  • [27] COVID-19 associated rhino-orbito-cerebral mucormycosis, risk factors and outcome predictors; a multicentric study
    Mohammad Taher Rajabi
    Amirhossein Aghajani
    Seyed Mohsen Rafizadeh
    Mansooreh Jamshidian Tehrani
    Seyedeh Zahra Poursayed Lazarjani
    Mohammad Mohsen Keshmirshekan
    Abbas Mohammadi
    Abbas Akrami
    Mohammad Mehdi Parandin
    Mohammad Bagher Rajabi
    Seyede Simindokht Hosseini
    Maryam Akbari
    International Ophthalmology, 2023, 43 : 1375 - 1386
  • [28] Pathogenetic factors fanning the flames of COVID-19 to cause rhino-orbito-cerebral mucormycosis: An observational study
    Reddy, Y. Muralidhar
    Yeduguri, Sreekanth
    Reddy, Vishnu Swaroop N.
    Parida, Subhendu
    Kamatham, Shanti Naidu
    Pidaparthi, Lalitha
    Jaiswal, Shyam K.
    Sadhvani, Bhavana
    Tourani, Vijaya
    Kumar, Sudhir
    Challa, Sundaram
    Murthy, Jagarlapudi Mk
    JOURNAL DE MYCOLOGIE MEDICALE, 2022, 32 (02):
  • [29] COVID-19-associated rhino-orbito-cerebral mucormycosis: a single center prospective study of 264 patients
    Kim, Usha
    Perzia, Brittany
    Kulkarni, Pooja
    Rajiniganth, Mahalingam
    Sundar, Balagiri
    Robin, Alan L.
    Shukla, Aakriti Garg
    Maeng, Michelle M.
    ORBIT-THE INTERNATIONAL JOURNAL ON ORBITAL DISORDERS-OCULOPLASTIC AND LACRIMAL SURGERY, 2025, 44 (01): : 24 - 33
  • [30] Spectrum of magnetic resonance imaging findings in post-COVID-19 patients presenting with rhino-orbito-cerebral mucormycosis in a teaching hospital in Malwa region of Punjab
    Singh, Pushpinder
    Kaur, Kiranjeet
    Jindal, Vinita
    Kaur, Manjot
    Kaur, Mandeep
    Singh, Navdeep
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2022, 11 (12) : 7788 - 7794